CSIMarket
 
Stryker Corp  (NYSE: SYK)
Other Ticker:  
 
 
Price: $357.4800 $9.36 2.689%
Day's High: $368.365 Week Perf: 3.09 %
Day's Low: $ 355.10 30 Day Perf: -4.49 %
Volume (M): 421 52 Wk High: $ 406.19
Volume (M$): $ 153,837 52 Wk Avg: $359.33
Open: $355.11 52 Wk Low: $314.93



 Market Capitalization (Millions $) 138,095
 Shares Outstanding (Millions) 386
 Employees 52,000
 Revenues (TTM) (Millions $) 22,595
 Net Income (TTM) (Millions $) 2,993
 Cash Flow (TTM) (Millions $) 681
 Capital Exp. (TTM) (Millions $) 755

Stryker Corp
Company Profile: Stryker Corporation

Overview:
Stryker Corporation is a leading global medical device company, renowned for its innovative products and solutions in the orthopaedic market. Founded in 1946 in Michigan as a successor to a business established by Dr. Homer H. Stryker, a pioneering orthopaedic surgeon, the company has since evolved into one of the largest and most respected entities in the medical field.

Core Competencies:
Stryker specializes in a comprehensive array of medical devices and technologies, which include:

- Orthopaedic Products: Joint replacements, trauma devices, spinal systems, and micro-implant technologies.
- Orthobiologics: Innovative solutions to enhance healing practices and improve outcomes for patients undergoing surgery.
- Surgical Instruments: Advanced powered surgical instruments and navigation systems that enhance the precision and efficiency of surgical procedures.
- Endoscopic Products: Tools and devices designed for minimally invasive surgeries that improve patient recovery times and surgical outcomes.
- Emergency Medical Equipment: A range of patient handling solutions, including stretchers and transport devices, designed for emergency medical services.
- Outpatient Physical Therapy: Stryker also offers outpatient physical therapy services across the United States, focusing on recovery and rehabilitation.

Mission and Vision:
Stryker is committed to advancing healthcare by providing innovative products and services that meet the needs of healthcare professionals and their patients. The company aims to enhance patient care through continuous innovation and excellence in the design and manufacturing of medical devices.

Global Presence:
Operating in multiple countries around the world, Stryker Corporation leverages its expansive distribution network to reach a wide variety of healthcare settings, from hospitals to outpatient facilities.

Recent Developments:
Stryker remains at the forefront of medical technology, continually investing in research and development to bring cutting-edge solutions and products to market. The companys strong emphasis on innovation and quality has solidified its reputation as a trusted partner in the healthcare industry.

Commitment to Sustainability:
Stryker is dedicated to sustainability and corporate responsibility, focusing on minimizing its environmental impact and contributing positively to the communities it serves.

With a robust portfolio and a strong foundation built on a legacy of innovation, Stryker Corporation is well-positioned to lead the medical device industry into the future.


   Company Address: 1941 Stryker Way, Portage, 49002 MI
   Company Phone Number: 385-2600   Stock Exchange / Ticker: NYSE SYK


Customers Net Income grew by SYK's Customers Net Profit Margin grew to

39.97 %

1.17 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BAX        2.56% 
BDX        1.83% 
BSX        4.02% 
ISRG        1.21% 
MDT        1.41% 
ZBH        1.65% 
• View Complete Report
   



Dividend

Strykers Dividend Boost Fortifies Shareholder Confidence Amid Continued Stock Surge,

Published Wed, Feb 5 2025 1:01 PM UTC

Stryker s Steady Dividend Growth Signals Confidence Amid Market MomentumIn a strategic move that underscores its commitment to shareholder returns, Stryker Corporation (NYSE: SYK) announced a quarterly dividend of $0.84 per share, payable on April 30, 2025. The decision came from the company?s Board of Directors and reflects a 5% increase compared to the same period last yea...

Management Changes

Stryker Corporation Announces CFO Transition as Glenn Boehnlein Retires After 22 Years,

Published Tue, Jan 28 2025 9:05 PM UTC

Stryker Corp Announces Leadership Transition as CFO Glenn Boehnlein Retires After 22 YearsStryker Corporation (NYSE: SYK) is set to embark on a new chapter as the company announces the retirement of Glenn S. Boehnlein from his role as Vice President and Chief Financial Officer (CFO). This significant leadership transition comes after an impressive 22-year tenure, during whic...

Announcement

Strykers Stride Balancing Revenue Gains with Economic Realities,

Published Mon, Jan 6 2025 1:39 PM UTC

Stryker s Financial Horizon: Navigating Robust Revenues and Rising Costs Stryker Corporation (NYSE: SYK), a prominent player in the medical technology sector, is gearing up to announce its financial results for the fourth quarter and full year 2024 on January 28, 2025. Ahead of the anticipated report, a detailed look at the company s annual performance reveals a landscape o...

Dividend

Dividend Dynamics: Stryker?s 5% Increase Reflects Robust Growth Amid Healthcare Competition,

Published Tue, Dec 10 2024 1:00 PM UTC

Stryker s Strategic Dividend Increase Signals Robust Financial Health Amidst Industry CompetitionOn December 10, 2024, Stryker Corporation (NYSE: SYK) made...

Announcement

Stryker Corporation Prepares for Financial Transparency Third Quarter and Second Quarter Results Announced

Published Tue, Oct 1 2024 8:00 PM UTC

In the ever-evolving landscape of the healthcare industry, Stryker Corporation continues to establish itself as a leader, showing remarkable resilience and commitment to financial accountability. Based in Portage, Michigan, Stryker (NYSE:SYK) is set to unveil its third quarter financial results for fiscal year 2024 on October 29, 2024. This announcement aligns perfectly with...







Stryker's Segments
United States    74.79 % of total Revenue
International    25.21 % of total Revenue
MedSurg and Neurotechnology    58.68 % of total Revenue
MedSurg and Neurotechnology United States    45.56 % of total Revenue
MedSurg and Neurotechnology International    13.12 % of total Revenue
MedSurg and Neurotechnology Instruments    12.36 % of total Revenue
MedSurg and Neurotechnology Instruments United States    9.9 % of total Revenue
MedSurg and Neurotechnology Instruments International    2.46 % of total Revenue
MedSurg and Neurotechnology Endoscopy    15.23 % of total Revenue
MedSurg and Neurotechnology Endoscopy United States    12.54 % of total Revenue
MedSurg and Neurotechnology Endoscopy International    2.69 % of total Revenue
MedSurg and Neurotechnology Medical    17.07 % of total Revenue
MedSurg and Neurotechnology Medical United States    14.25 % of total Revenue
MedSurg and Neurotechnology Medical International    2.82 % of total Revenue
MedSurg and Neurotechnology Neurovascular    5.99 % of total Revenue
MedSurg and Neurotechnology Neurovascular United States    2.2 % of total Revenue
MedSurg and Neurotechnology Neurovascular International    3.79 % of total Revenue
MedSurg and Neurotechnology Neuro Cranial    8.03 % of total Revenue
MedSurg and Neurotechnology Neuro Cranial United States    6.66 % of total Revenue
MedSurg and Neurotechnology Neuro Cranial International    1.37 % of total Revenue
Orthopaedics and Spine    41.32 % of total Revenue
Orthopaedics and Spine United States    29.23 % of total Revenue
Orthopaedics and Spine International    12.09 % of total Revenue
Orthopaedics and Spine Knees    10.37 % of total Revenue
Orthopaedics and Spine Knees United States    7.59 % of total Revenue
Orthopaedics and Spine Knees International    2.78 % of total Revenue
Orthopaedics and Spine Hips    7.64 % of total Revenue
Orthopaedics and Spine Hips United States    4.66 % of total Revenue
Orthopaedics and Spine Hips International    2.99 % of total Revenue
Orthopaedics and Spine Trauma and Extremities    15.45 % of total Revenue
Orthopaedics and Spine Trauma and Extremities United States    11.3 % of total Revenue
Orthopaedics and Spine Trauma and Extremities International    4.15 % of total Revenue
Orthopaedics and Spine Spine    5.53 % of total Revenue
Orthopaedics and Spine Spine United States    4.1 % of total Revenue
Orthopaedics and Spine Spine International    1.44 % of total Revenue
Orthopaedics and Spine Other    2.31 % of total Revenue
Orthopaedics and Spine Other United States    1.58 % of total Revenue
Orthopaedics and Spine Other International    0.73 % of total Revenue





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com